STOCK TITAN

22Nd Century (XXII) Stock News

XXII Nasdaq

Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.

22nd Century Group Inc. develops and commercializes reduced-nicotine tobacco products built on proprietary plant biotechnology. Its VLN® combustible cigarette products use low-nicotine tobacco and are described in company materials as FDA-authorized reduced nicotine cigarettes in the United States. Company updates commonly address VLN retail distribution, state authorizations, PMTA-related product expansion, licensing strategy, tobacco-variety research and engagement with FDA and public-health stakeholders.

News also covers operating results for the tobacco business, including branded VLN products, contract manufacturing volumes, filtered cigars and other distributed tobacco products. Recent company reporting frames results around commercial expansion, cost management, higher-margin branded products and the completed exit from the hemp/cannabis business.

Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced it will participate in the HC Wainwright Conference on September 15, 2026 at the Lotte New York Palace Hotel in New York. Chairman and CEO Larry Firestone and CFO Dan Otto are scheduled to attend, and investors can register and request meetings through their HC Wainwright representative.

The company highlighted its proprietary non-GMO reduced-nicotine tobacco plants, which contain about 95% less nicotine than traditional tobacco plants, and its VLN and Pinnacle VLN cigarettes. According to 22nd Century Group, VLN cigarettes are the only low-nicotine combustible cigarettes authorized by the FDA in the United States.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) reported second quarter 2026 net revenues of $2.9 million, down from $4.1 million in the prior quarter and $4.1 million a year ago. Gross loss improved to $0.3 million, while operating loss widened to $3.3 million and net loss was $3.3 million. Adjusted EBITDA loss was $3.5 million. The company ended the quarter with $6.1 million in cash and no debt.

According to 22nd Century Group, cigarette revenues declined as it shifted away from low-priced export customers toward higher-margin VLN® products. The company expanded Pinnacle VLN® distribution by about 150 stores in metro New York/New Jersey, initiated launches in roughly 60 California stores, and now has a presence in more than 2,000 outlets across 20 states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.64%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) will release its second quarter 2026 financial results via press release at approximately 6:00 AM ET on Thursday, August 13, 2026, followed by a webcast at 8:00 AM ET.

Chairman and CEO Larry Firestone and CFO Dan Otto will review financial performance, discuss second-quarter progress, and provide an update on plans for full-year 2026. Investors can access the live and archived webcast through the Events page in the Investor Relations section of the company’s website, with early log-in recommended for registration and any necessary software installation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
earnings date
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) has appointed Katherine Rouse-Bailey as Vice President of Marketing to support expanded marketing initiatives for its VLN® and Pinnacle® cigarette brands. The company aims to strengthen brand awareness, increase consumer trial, and support retail sell-through across its growing commercial footprint in the second half of 2026 and beyond.

Rouse-Bailey brings 20 years of consumer health marketing experience at Johnson & Johnson, Galderma and Nestlé Health Science, with an MBA and science degrees. According to 22nd Century Group, the initiatives will build on momentum from the Q4 2025 VLN® launch and its broader VLN® commercialization strategy, supported by FDA authorization of VLN® low nicotine cigarettes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.15%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) launched a Pinnacle VLN® reduced-nicotine cigarette retail trial in California, entering about 60 stores initially.

The launch creates the brand’s first California retail presence and a pathway that, if expanded, could reach 2,000+ additional outlets in one of the nation’s largest, policy‑driven tobacco markets.

VLN® is the first and, according to the company, still the only combustible cigarette FDA-authorized to help reduce nicotine consumption, with claims such as “95% less nicotine” and “Helps reduce your nicotine consumption.”

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.84%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced the launch of Pinnacle Pure, a new tobacco and water style combustible cigarette, expected to roll out in Q2 2026 across multiple top U.S. national retailers and over 2,000 locations.

Pinnacle Pure extends the fast-scaling, high-margin Pinnacle platform, which already includes cigarettes, VLN products, moist snuff, and cigarillos, and is positioned to support revenue growth, margin expansion, and broader retail penetration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.59%
Tags
none
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced a major retail expansion of its Pinnacle VLN® low-nicotine cigarettes into nearly 150 metro New York and northern New Jersey stores operated by one of the nation’s largest cigarette retailers.

The rollout targets a corridor with an estimated 800,000 adult smokers, aims to drive high-margin revenue, expand brand visibility, and support progress toward cash-positive operations. VLN® remains the only FDA-authorized combustible cigarette specifically for reduced nicotine consumption.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.95%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced that the FDA has filed for scientific review renewal applications for its VLN King and VLN Menthol King Modified Risk Tobacco Products. These combusted cigarettes currently carry exposure‑modification orders that expire in December 2026 unless renewed.

The renewal seeks to preserve VLN’s authorized reduced‑nicotine claims, including “95% less nicotine” and related reduced consumption statements, and is supported by prior FDA findings and new marketplace data, including a 2024 study showing a 40% reduction in daily cigarette consumption over 12 weeks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) reported first quarter 2026 results and business updates on May 7, 2026. The company reported net revenues of $4.1 million, a net loss of $3.3 million, adjusted EBITDA loss of $2.6 million, and $9.5 million in cash at quarter end.

Operational highlights include VLN® placement in over 2,000 stores across 20 states, a target to reach 5,000 retail outlets by end-2026, multiple PMTA submissions across combustible categories, completed 100mm product prototyping, and zero long-term debt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.35%
Tags
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) will report first quarter 2026 results on May 7, 2026. A press release will be issued at 6:00 AM ET, followed by a live webcast at 8:00 AM ET with CEO Larry Firestone and CFO Dan Otto.

The webcast and archived replay are available on the company’s Events page. The company highlights its FDA‑authorized VLN® cigarette, made with proprietary tobacco that contains 95% less nicotine than traditional cigarettes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.59%
Tags
earnings date

FAQ

What is the current stock price of 22Nd Century (XXII)?

The current stock price of 22Nd Century (XXII) is $2.13 as of September 9, 2026.

What is the market cap of 22Nd Century (XXII)?

The market cap of 22Nd Century (XXII) is approximately 1.5M.